DOWN-REGULATION OF ADENYLYLCYCLASE TYPE-V AND TYPE-VI MESSENGER-RNA LEVELS IN PACING-INDUCED HEART-FAILURE IN DOGS

被引:114
作者
ISHIKAWA, Y
SOROTA, S
KIUCHI, K
SHANNON, RP
KOMAMURA, K
KATSUSHIKA, S
VATNER, DE
VATNER, SF
HOMCY, CJ
机构
[1] AMER CYANAMID CO,LEDERLE LABS,DIV MED RES,PEARL RIVER,NY 10965
[2] COLUMBIA UNIV,COLL PHYS & SURG,DEPT PHARMACOL,NEW YORK,NY 10032
[3] COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032
[4] HARVARD UNIV,NEW ENGLAND REG PRIMATE RES CTR,SCH MED,DEPT MED,SOUTHBOROUGH,MA 01772
关键词
CARDIAC ADENYLYLCYCLASE; MESSENGER-RNA; HEART FAILURE; CARDIAC PACING; DOWN-REGULATION;
D O I
10.1172/JCI117219
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have shown that the heart expresses two distinct forms of adenylylcyclase mRNA, types V and VI. In this study we have characterized the expression of these two mRNA species in heart failure generated by overdrive pacing at a rate of 240 beats/min. After 4 wk, left ventricular end-diastolic pressure and heart rate increased significantly with the appearance of signs of heart failure, i.e., edema, ascites, and exercise intolerance. Basal as well as forskolin-stimulated adenylylcyclase activities decreased significantly, which was accompanied by a reduction in the steady state mRNA levels of adenylylcyclase types V and VI. These data suggest that in this model of cardiomyopathy, the downregulation of adenylylcyclase catalytic activity results, at least in part, from a reduction in the steady state levels of types V and VI adenylylcyclase mRNA levels.
引用
收藏
页码:2224 / 2229
页数:6
相关论文
共 38 条
[1]   IDENTIFICATION OF A SPECIALIZED ADENYLYL CYCLASE THAT MAY MEDIATE ODORANT DETECTION [J].
BAKALYAR, HA ;
REED, RR .
SCIENCE, 1990, 250 (4986) :1403-1406
[2]  
BELL JD, 1985, J BIOL CHEM, V260, P2625
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   PHARMACOLOGY AND INOTROPIC POTENTIAL OF FORSKOLIN IN THE HUMAN-HEART [J].
BRISTOW, MR ;
GINSBURG, R ;
STROSBERG, A ;
MONTGOMERY, W ;
MINOBE, W .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (01) :212-223
[5]   DIFFERENCES IN BETA-ADRENERGIC NEUROEFFECTOR MECHANISMS IN ISCHEMIC VERSUS IDIOPATHIC DILATED CARDIOMYOPATHY [J].
BRISTOW, MR ;
ANDERSON, FL ;
PORT, JD ;
SKERL, L ;
HERSHBERGER, RE ;
LARRABEE, P ;
OCONNELL, JB ;
RENLUND, DG ;
VOLKMAN, K ;
MURRAY, J ;
FELDMAN, AM .
CIRCULATION, 1991, 84 (03) :1024-1039
[6]   DYSFUNCTION OF THE BETA-ADRENERGIC AND ALPHA-ADRENERGIC SYSTEMS IN A MODEL OF CONGESTIVE-HEART-FAILURE - THE PACING-OVERDRIVE DOG [J].
CALDERONE, A ;
BOUVIER, M ;
LI, K ;
JUNEAU, C ;
DECHAMPLAIN, J ;
ROULEAU, JL .
CIRCULATION RESEARCH, 1991, 69 (02) :332-343
[7]   DECREASED-GS-ALPHA MESSENGER-RNA LEVELS ACCOMPANY THE FALL IN GS AND ADENYLYL CYCLASE ACTIVITIES IN COMPENSATED LEFT-VENTRICULAR HYPERTROPHY - IN HEART-FAILURE, ONLY THE IMPAIRMENT IN ADENYLYL CYCLASE ACTIVATION PROGRESSES [J].
CHEN, LA ;
VATNER, DE ;
VATNER, SF ;
HITTINGER, L ;
HOMCY, CJ .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) :293-298
[8]   REVERSIBILITY OF TACHYCARDIA-INDUCED CARDIOMYOPATHY AFTER CURE OF INCESSANT SUPRAVENTRICULAR TACHYCARDIA [J].
CRUZ, FES ;
CHERIEX, EC ;
SMEETS, JLRM ;
ATIE, J ;
PERES, AK ;
PENN, OCKM ;
BRUGADA, P ;
WELLENS, HJJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (03) :739-744
[9]  
FEDERMAN AD, 1992, SCIENCE, V356, P159
[10]   MOLECULAR-CLONING AND CHARACTERIZATION OF A CA2+ CALMODULIN-INSENSITIVE ADENYLYL CYCLASE FROM RAT-BRAIN [J].
FEINSTEIN, PG ;
SCHRADER, KA ;
BAKALYAR, HA ;
TANG, WJ ;
KRUPINSKI, J ;
GILMAN, AG ;
REED, RR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10173-10177